Opioid 411 in 2023 (3-hour)
SELF STUDY COURSE
3 Race-approved, Non-Interactive CE hours (1 Medical, 2 Non-Medical)
CE Type: Self Study Course
Tuition: drip.vet $74.99
Instructors:
- Lance Roasa, DVM, JD, MS
- Bree Montana, DVM, CCFP
- Philip J. Seibert, Jr., CVT
-
Rachael E. Carpenter, DVM
Description:
This course fulfills mandates in states that mandate continuing education in opioids and controlled substances. It provides learners with a broad range of expert-level knowledge on subjects including federal controlled substance laws, best practices for prescribing and management of controlled substances including benzodiazepine and opioid medications, use of electronic PDMPs, dispensing controlled substances, recognition of substance abuse, signs of opioid abuse, addiction and diversion, opioid use and dependency in office staff, clients and co-workers, use, misuse, documentation, safeguarding and monitoring controlled substances, controlled substance diversion, inventory and security, treatment of chronic pain, and controlled substance prescribing for chronic pain management.
Visit your State CE Hub for current information or if you have questions about the requirements.
Learning Objectives:
Upon completion of the course, the participant should be able to:
Introduce the topic, review statistics & discuss federal controlled substance laws
- Review best practices for prescribing controlled substances, including benzodiazepine & opioid medications
- Discuss dispensing of controlled substances
- Review use of state electronic PDMP systems
- Review how to recognize substance abuse
- Discuss the signs of opioid abuse & addiction
- Review opioid use & dependency in office staff, clients & co-workers
- Review the management of controlled substances, including benzodiazepine & opioid medications
- Discuss the signs of opioid diversion
- Review the use, misuse, documentation & safeguarding of controlled substances
Curriculum
Preview course curriculum by clicking the "Preview" button below.
- drip alpha - Course Transcript, Slide Deck, and Resources
- drip 1 - Introduction and Statistics (6:20)
- drip 2 - Discussion of Federal Laws (8:04)
- drip 3 - Best Practices and PDMP Systems (6:47)
- drip 4 - Dispensing Controlled Substances (8:20)
- Poll Question #1
- drip 5 - Recognizing Abuse (6:14)
- drip 6 - Signs of Addiction and Dependency (7:15)
- drip 7 - Warning Signs (8:09)
- drip 8 - Other Commonly Abused Drugs (8:34)
- Poll Question #2
- drip 9 - Access, Qualifications, and Diversion (8:47)
- drip 10 - Management of Controlled Substances (7:35)
- drip 11 - Use, Misuse, Documentation, and Safeguarding (6:33)
- drip 12 - Monitoring, Inventory, and Security (8:34)
- Poll Question #3
- drip 13 - Chronic Pain Treatment (6:32)
- drip 14 - Signs of Chronic Pain (7:44)
- drip 15 - NSAIDs, Monoclonal Antibodies, and Other Alternatives (9:28)
- drip 16 - Nonpharmacologic Techniques for Pain Management (5:38)
- Poll Question #4
- drip 17 - Approach to Suspicions of an Addicted Colleague (7:08)
- drip 18 - Qualifications to Access Controlled Drugs (7:55)
- drip 19 - Concomitant use of Monoclonal Antibodies and NSAIDs (9:58)
- drip 20 - Multimodal Pain Management (10:44)
- drip 21 - Doctor Shopping Documentation (6:26)